{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:23:24Z","timestamp":1793877804534,"version":"4.7.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is often fatal. A straightforward staging system for AE-IPF would improve prognostication, guide patient management, and facilitate research. The aim of study is to develop a multidimensional prognostic AE-IPF staging system that uses commonly measured clinical variables. This retrospective study analyzed data from 353 consecutive patients with IPF admitted to our hospital during the period from January 2008 through January 2018. Multivariate analysis of information from a database of 103 recorded AE-IPF cases was used to identify factors associated with 3-month mortality. A clinical prediction model for AE-IPF was developed by using these retrospective data. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of this model. Logistic regression analysis showed that PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio, diffuse HRCT pattern, and serum C-reactive protein (CRP) were significantly associated with 3-month mortality; thus, PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio\u2009&lt;\u2009250 (P), CRP\u2009\u2265\u20095.5 (C), and diffuse HRCT pattern (radiological) (R) were included in the final model. A model using continuous predictors and a simple point-scoring system (PCR index) was developed. For the PCR index, the area under the ROC curve was 0.7686 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). The sensitivity of the scoring system was 78.6% and specificity was 67.8%. The PCR index identified four severity grades (0, 1, 2, and 3), which were associated with a 3-month mortality of 7.7%, 29.4%, 54.8%, and 80%, respectively. The present PCR models using commonly measured clinical and radiologic variables predicted 3-month mortality in patients with AE-IPF.<\/jats:p>","DOI":"10.1038\/s41598-022-05138-6","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:02:41Z","timestamp":1642762961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Susumu","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Isshiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"3","key":"5138_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard, H. R. et al. Acute exacerbation of idiopathic pulmonary fibrosis: An international working group report. Am. J. Respir. Crit. Care Med. 194(3), 265\u2013275 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"5138_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard, H. R. et al. Idiopathic pulmonary fibrosis clinical research network investigators. Acute exacerbation of idiopathic fibrosis. Am. J. Respir. Crit. Care Med. 176(7), 636\u201343 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"5138_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. ATS\/ERS\/JRS\/ALAT Committee on idiopathic pulmonary fibrosis: An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183(6), 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"145","key":"5138_CR4","doi-asserted-by":"publisher","first-page":"170050","DOI":"10.1183\/16000617.0050-2017","volume":"26","author":"Y Kondoh","year":"2017","unstructured":"Kondoh, Y., Cottin, V. & Brown, K. K. Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis. Eur. Respir. Rev. 26(145), 170050 (2017).","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"5138_CR5","doi-asserted-by":"publisher","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","volume":"53","author":"D Singh","year":"2019","unstructured":"Singh, D. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. Eur. Respir. J. 53(5), 1900164 (2019).","journal-title":"Eur. Respir. J."},{"issue":"9","key":"5138_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jtho.2017.06.003","volume":"12","author":"K Aokage","year":"2017","unstructured":"Aokage, K. et al. Clinical and pathological staging validation in the eighth edition of the TNM classification for lung cancer: Correlation between solid size on thin-section computed tomography and invasive size in pathological findings in the new T classification. J. Thorac. Oncol. 12(9), 1403\u20131412 (2017).","journal-title":"J. Thorac. Oncol."},{"issue":"10","key":"5138_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley, B. et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 156(10), 684\u2013691 (2012).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"5138_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.resinv.2014.08.003","volume":"53","author":"S Homma","year":"2015","unstructured":"Homma, S., Sugino, K. & Sakamoto, S. Usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment. Respir. Investig. 53(1), 7\u201312 (2015).","journal-title":"Respir. Investig."},{"issue":"1","key":"5138_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00408-013-9530-0","volume":"192","author":"T Kishaba","year":"2014","unstructured":"Kishaba, T., Tamaki, H. & Shimaoka, Y. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung 192(1), 141\u2013149 (2014).","journal-title":"Lung"},{"issue":"5","key":"5138_CR10","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu, G. et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 198(5), e44\u2013e68 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"5138_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.200709-1365OC","volume":"178","author":"M Akira","year":"2008","unstructured":"Akira, M., Kozuka, T., Yamamoto, S. & Sakatani, M. Computed tomography findings of acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178(4), 372\u2013378 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"5138_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00330-011-2211-6","volume":"22","author":"K Fujimoto","year":"2012","unstructured":"Fujimoto, K. et al. Acute exacerbation of idiopathic pulmonary fibrosis: High-resolution CT scores predict mortality. Eur. Radiol. 22(1), 83\u201392 (2012).","journal-title":"Eur. Radiol."},{"issue":"1","key":"5138_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.09-1002","volume":"137","author":"ER Fern\u00e1ndez P\u00e9rez","year":"2010","unstructured":"Fern\u00e1ndez P\u00e9rez, E. R. et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest 137(1), 129\u2013137 (2010).","journal-title":"Chest"},{"issue":"4","key":"5138_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1513\/pats.200601-005TK","volume":"3","author":"DS Kim","year":"2006","unstructured":"Kim, D. S., Collard, H. R. & King, T. E. Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc. 3(4), 285\u2013292 (2006).","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"3","key":"5138_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000369828","volume":"89","author":"T Isshiki","year":"2015","unstructured":"Isshiki, T. et al. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study. Respiration 89(3), 201\u2013207 (2015).","journal-title":"Respiration"},{"key":"5138_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1378\/chest.14-2746","volume":"148","author":"K Kataoka","year":"2015","unstructured":"Kataoka, K. et al. Recombinant human thrombomodulin in acute exacerbation of idiopathic pulmonary fibrosis. Chest 148, 436\u2013443 (2015).","journal-title":"Chest"},{"issue":"11","key":"5138_CR17","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1164\/rccm.2106157","volume":"165","author":"K Ichikado","year":"2002","unstructured":"Ichikado, K. et al. Acute interstitial pneumonia: Comparison of high-resolution computed tomography findings between survivors and non-survivors. Am. J. Respir. Crit. Care Med. 165(11), 1551\u20131556 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"5138_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1148\/radiol.2373041515","volume":"238","author":"K Ichikado","year":"2006","unstructured":"Ichikado, K. et al. Prediction of prognosis for acute respiratory distress syndrome with thin section CT: Validation in 44 cases. Radiology 238(1), 321\u2013329 (2006).","journal-title":"Radiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05138-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:24:47Z","timestamp":1669325087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5138"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05138-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"27 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1134"}}